688710.SHG INNOSTAR ORD A (SHH) EQSW Exp:

Healthcare Drug Manufacturers - General Shanghai Stock Exchange
92.00 CNY
Close of Nov 5, 2026
40.26 112.00
Market cap
CNY 13.0B
P/E
167.3x
P/B
4.60x
ROE
5.2%
Dividend yield
0.35%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 688710.SHG undervalued?

Graham number

The Graham number of INNOSTAR ORD A (SHH) EQSW Exp: cannot be estimated reliably (the estimate is too far from the market price).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

INNOSTAR ORD A (SHH) EQSW Exp: fundamental analysis

No fundamental analysis for INNOSTAR ORD A (SHH) EQSW Exp: yet.

INNOSTAR ORD A (SHH) EQSW Exp: stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About INNOSTAR ORD A (SHH) EQSW Exp:

Shanghai InnoStar Bio-tech Co., Ltd. provides drug research and development services in China and internationally. It offers screening, nonclinical assessment stage, and clinical development stage services in the areas of chemical products, biologics, cell and gene therapeutics, radiopharmaceuticals, and traditional Chinese medicines. The company was founded in 2010 and is based in Shanghai, China.

Full company profile